Clinicopathological relevance of SMAD4 and RUNX3 in pancreatic cancer

被引：0
|
作者：
Hirose, Katsuya [1 ]
Yamamoto, Masakazu [2 ]
Furukawa, Toru [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Histopathol, Sendai, Miyagi, Japan
[2] Tokyo Womens Med Univ, Dept Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3366
引用
收藏
页码：1419 / 1419
页数：1
相关论文
共 50 条
  • [1] The Potency of SMAD4 and RUNX3 as Markers of Prognostic Prediction
    Hirose, K.
    Omori, Y.
    Higuchi, R.
    Yamamoto, M.
    Furukawa, T.
    PANCREAS, 2019, 48 (10) : 1443 - 1443
  • [2] Analysis of clinicopathological features by SMAD4 immunohistochemistry in pancreatic cancer.
    Matsumura, Kazuki
    Hayashi, Hiromitsu
    Zhao, Liu
    Sato, Hiroki
    Kitamura, Fumimasa
    Kaida, Takayoshi
    Nakagawa, Shigeki
    Mima, Kosuke
    Imai, Katsunori
    Yamashita, Yoichi
    Baba, Hideo
    CANCER SCIENCE, 2022, 113 : 570 - 570
  • [3] RUNX3、SMAD4、VEGF在人胃癌中的表达及意义
    雷兰英
    杨桂芳
    张振东
    龚玲玲
    刘欢
    徐志高
    汪必成
    罗峻
    田素芳
    武汉大学学报(医学版), 2010, 31 (04) : 451 - 454
  • [4] SMAD4 and its role in pancreatic cancer
    Xia, Xiang
    Wu, Weidong
    Huang, Chen
    Cen, Gang
    Jiang, Tao
    Cao, Jun
    Huang, Kejian
    Qiu, Zhengjun
    TUMOR BIOLOGY, 2015, 36 (01) : 111 - 119
  • [5] Runx3与Smad4在食管鳞癌中表达和临床意义
    王金
    柴磊
    吴艳萍
    苗雨
    阮继刚
    中国老年学杂志, 2018, 38 (02) : 286 - 288
  • [6] Runx3和Smad4在胃癌中的表达及其临床意义
    王亚东
    胡敏
    辽宁中医药大学学报, 2010, 12 (06) : 127 - 129
  • [7] Combination Immunohistochemistry for SMAD4 and Runt-Related Transcription Factor 3 (RUNX3) May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas
    Lee, Yangkyu
    Lee, Hyejung
    Park, Hyunjin
    Kim, Jin-Won
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Kim, Haeryoung
    LABORATORY INVESTIGATION, 2017, 97 : 446A - 446A
  • [8] Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 (RUNX3) may identify a favourable prognostic subgroup of pancreatic ductal adenocarcinomas
    Lee, Y. -K.
    Lee, H. -J.
    Park, H. -J.
    Kim, J. -W.
    Hwang, J. -H.
    Kim, J. -H.
    Yoon, Y. -S.
    Han, H. -S.
    Lee, K. -S.
    Shin, E.
    Kim, H. -Y.
    VIRCHOWS ARCHIV, 2016, 469 : S86 - S86
  • [9] Combination Immunohistochemistry for SMAD4 and Runt-Related Transcription Factor 3 (RUNX3) May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas
    Lee, Yangkyu
    Lee, Hyejung
    Park, Hyunjin
    Kim, Jin-Won
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Kim, Haoyoung
    MODERN PATHOLOGY, 2017, 30 : 446A - 446A
  • [10] RUNX3 expression in primary and metastatic pancreatic cancer
    Li, J
    Kleeff, J
    Guweidhi, A
    Esposito, I
    Berberat, PO
    Giese, T
    Büchler, MW
    Friess, H
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (03) : 294 - 299
12345